Zellner Tobias, Metzger Jan-Christopher, Bekka Elias, Rabaioli Matteo, Stock Konrad, Vo-Cong Minh-Truc, Schmoll Sabrina, Heier Eva-Carina, Eyer Florian, Stich Raphael
Division of Clinical Toxicology and Poison Centre Munich, Department of Internal Medicine II, TUM School of Medicine and Health, TUM University Hospital, Technical University of Munich, Munich, Germany.
Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
PLoS One. 2025 Mar 19;20(3):e0320083. doi: 10.1371/journal.pone.0320083. eCollection 2025.
To determine if increased liver stiffness (ILS) is a risk factor for patients with alcohol withdrawal to develop severe alcohol withdrawal symptoms (SAWS) like delirium tremens (DT) or withdrawal seizures (WS).
Prospective inclusion of 394 patients undergoing withdrawal treatment between 2013-2021. Laboratory exams, history, physical examination, abdominal sonography with elastography and FibroScan® measurements were performed. Primary endpoint was SAWS defined as DT and/or WS. Patients with > 12.5 kPa stiffness in FibroScan® and > 1.75 m/s in Acoustic Radiation Force Impulse Imaging were considered ILS, patients with both measurements below the respective cut-off were ILS negative. Univariate analysis with receiver operating characteristic curve analysis and multivariate analysis were performed.
78 patients (19.8%) had ILS. Of these, 28 patients developed complications despite treatment. SAWS correlated significantly with patients with ILS. Further significant correlations were emergency hospital admission, Alcohol Withdrawal Scale ≥ 5, lower potassium, elevated bilirubin, increased Gamma-GT, thrombocytopenia, previous WS, and previous DT. In multivariate binary regression analysis, odds ratio for SAWS was 5.4 for emergency admission, 3.5 for previous DT and 2.2 for ILS, even if the significance level for the last parameter was missed.
Patients with ILS have an increased risk of developing SAWS, as well as patients with emergency admission and previous DT among other markers. Treatment in an appropriately equipped facility is recommended for patients with this risk profile which can be measured easily by a general practitioner or in an emergency department.
确定肝脏硬度增加(ILS)是否是酒精戒断患者出现严重酒精戒断症状(SAWS)如震颤谵妄(DT)或戒断性癫痫(WS)的危险因素。
前瞻性纳入2013年至2021年间接受戒断治疗的394例患者。进行实验室检查、病史采集、体格检查、腹部超声弹性成像和FibroScan®测量。主要终点是定义为DT和/或WS的SAWS。FibroScan®硬度> 12.5 kPa且声辐射力脉冲成像> 1.75 m/s的患者被视为ILS阳性,两项测量均低于各自临界值的患者为ILS阴性。进行了单因素分析、受试者工作特征曲线分析和多因素分析。
78例患者(19.8%)有ILS。其中,28例患者尽管接受了治疗仍出现并发症。SAWS与ILS患者显著相关。其他显著相关因素包括急诊入院、酒精戒断量表≥ 5、低钾、胆红素升高、γ-谷氨酰转肽酶升高、血小板减少、既往WS和既往DT。在多因素二元回归分析中,急诊入院时SAWS的比值比为5.4,既往DT为3.5,ILS为2.2,即使最后一个参数未达到显著性水平。
ILS患者以及急诊入院患者和既往DT患者等出现SAWS的风险增加。对于具有这种风险特征的患者,建议在设备适当的机构进行治疗,这种风险特征可由全科医生或急诊科轻松测量。